Haemonetics (HAE) Non-Current Debt (2010 - 2026)

Haemonetics' Non-Current Debt history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Non-Current Debt rose 32.38% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 32.38% YoY), while the FY2026 annual figure was $1.2 billion, up 32.38% from the prior year.
• Non-Current Debt was $1.2 billion for Q1 2026 at Haemonetics, up from $920.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.2 billion in Q4 2024 to a low of $559.4 million in Q2 2022.
• Historically, Non-Current Debt has averaged $885.6 million across 5 years, with a median of $827.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Non-Current Debt surged 116.29% in 2022, then dropped 24.58% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $756.8 million in 2022, then increased by 13.22% to $856.8 million in 2023, then jumped by 42.35% to $1.2 billion in 2024, then decreased by 24.58% to $920.0 million in 2025, then soared by 32.56% to $1.2 billion in 2026.
• The last three Non-Current Debt figures came in at $1.2 billion (Q1 2026), $920.0 million (Q4 2025), and $920.4 million (Q3 2025), per Business Quant data.